Idactamab (Anti-SLC1A5 / ASCT2)

Idactamab (Anti-SLC1A5 / ASCT2) is an IgG1-κ antibody with in vivo activity across a spectrum of hematological malignancies. Idactamab can be used to prepare MEDI7247, a potent and specific ADC targeting ASCT2 (SLC1A5). MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2352
Sku # A2352-1mg*5
Pricing 1mg*5, $970.00
Feedback